On Tuesday, Gentium reported that the European Commission has granted a Marketing Authorization for Defitelio for the treatment of severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy.
http://wallstcheatsheet.com/stocks/4-healthcare-stock-stories-ready-for-an-investment-checkup.html/
http://wallstcheatsheet.com/stocks/4-healthcare-stock-stories-ready-for-an-investment-checkup.html/
No comments:
Post a Comment